Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6520999 | 0.99 | RAB9A (0.43) | RAB9AALDH1A1SMN1; SMN2NPC1PKM | |
| SCHEMBL6523082 | 0.89 | KMT2A (0.45) | ALDH1A1SMN1; SMN2POLBELANEKDM4E | |
| SCHEMBL6515227 | 0.87 | MEN1 (0.45) | ALDH1A1SMN1; SMN2POLBHPGD | |
| SCHEMBL6514911 | 0.81 | ALDH1A1 (0.44) | RAB9AALDH1A1SMN1; SMN2NPC1HPGD | |
| SCHEMBL6515215 | 0.80 | ERCC5 (0.47) | RAB9ASMN1; SMN2NPC1EPHX2POLB | |
| SCHEMBL9355898 | 0.78 | EPHX2 (0.51) | ALDH1A1SMN1; SMN2EPHX2HPGDKDM4E | |
| SCHEMBL6516332 | 0.78 | ERCC5 (0.49) | RAB9AALDH1A1SMN1; SMN2NPC1HPGD | |
| SCHEMBL6519507 | 0.77 | EPHX2 (0.35) | SMN1; SMN2EPHX2 | |
| SCHEMBL6519195 | 0.76 | HTT (0.41) | RAB9AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL6523839 | 0.76 | HTT (0.41) | RAB9AALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | RAB9A 2333/4885ALDH1A1 1254/4885SMN1; SMN2 1768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.